|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Interest income | |||||
| Other income, net | |||||
| Change in fair value of warrant liabilities | |||||
| Change in fair value of earn-out shares | |||||
| Foreign currency transaction (gain) loss, net | |||||
| Loss before provision for income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Comprehensive loss, net of tax: | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive loss | |||||
| Net loss per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common stock outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...